| ACT | Adoptive T cell therapy |
| APC | Antigen presenting cells |
| APL | Altered peptide ligand |
| HLA | Human leucocyte antigen |
| CDR | Complementary-determining region |
| NSPM | Nonsynonymous point mutations |
| MHC | Major histocompatibility complex |
| MS PBMCs |
Mass spectrometry peripheral blood mononuclear cells |
| pMHC | Peptide-major histocompatibility complex |
| TAA | Tumor-associated antigen |
| TCR | T cell receptor |
| TILs | Tumor infiltrating lymphocytes |
| WES | Whole exome sequencing |